Asked by: Andrew Rosindell (Reform UK - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many patients received NHS electroshock therapy in every year since 2010 in (a) England and (b) Romford constituency.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
In line with National Institute for Clinical Excellence’s guidelines, electroconvulsive therapy (ECT) is used in current United Kingdom clinical practice as a treatment option for individuals with depressive illness, catatonia and mania, and is occasionally used to treat schizophrenia. The following table shows the number of patients who received National Health Service ECT in England every year since 2016:
Financial year | Number of patients receiving ECT in England |
2016/2017 | 346 |
2017/2018 | 441 |
2018/2019 | 326 |
2019/2020 | 572 |
2020/2021 | 464 |
2021/2022 | 571 |
2022/2023 | 609 |
2023/2024 | 717 |
2024/2025 | 955 |
Source: NHS England.
Notes:
Data is not available prior to 2016. This data is not available at a constituency level, and, although the data is collected at local authority level, NHS England has advised that there were no reported electroshock therapy contacts for patients in the Havering Local Authority during this period.
Asked by: Andrew Rosindell (Reform UK - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 November 2025 to Question 86606, what steps he has taken to ensure that citizens of British Overseas Territories have access to NHS services whilst resident in the UK.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
National Health Service care is provided free at the point of use to people who are ordinarily resident in the United Kingdom. Being ordinarily resident broadly means living in the UK on a lawful and properly settled basis. People who are not considered ordinarily resident in the UK are required to pay for healthcare in England unless an exemption applies.
If citizens of British Overseas Territories are assessed as being ordinarily resident in the UK, they are able to access NHS care free at the point of use.
Asked by: Andrew Rosindell (Reform UK - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how a) treatment plans b) payment plans are determined based on the patient’s status of i) British Citizen ii) Citizen of a British Overseas territory.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Treatment plans are agreed between clinicians and patients based on clinical needs. Only those who are not ordinarily resident in the United Kingdom are required to pay for healthcare in England unless an exemption applies. Payment plans are agreed between trusts and the patient based on their individual circumstances, and where it is appropriate to do so.
Asked by: Andrew Rosindell (Reform UK - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with the Government of Montserrat regarding the requirement that patients accept full financial liability for medivac costs and all overseas medical expenses prior to emergency evacuation, and whether this policy is consistent with UK support for the territory’s health budget and obligations under Article 73 of the UN Charter.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Foreign, Commonwealth and Development Office provides budget support to the Government of Montserrat. Specific healthcare budget allocations are a matter for the Government of Montserrat. The United Kingdom Government fulfils all its responsibilities under Article 73 of the United Nations Charter to promote the political, economic, social, and educational advancement of the overseas territories.
Asked by: Andrew Rosindell (Reform UK - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he has taken to help reduce cases of hypoglycaemia in a) England and b) the parliamentary constituency of Romford.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) has published advice on the management of type 1 diabetes, including advice on managing hypoglycaemia and hyperglycaemia, which is available at the following link:
https://cks.nice.org.uk/topics/diabetes-type-1/management/
NICE’s guidance includes the use of hybrid close loops (HCL) for type 1 diabetes which provide real time monitoring of glucose levels and administer insulin when needed to prevent hypoglycaemia and hyperglycaemia.
Following NICE’s guidance, NHS England developed a five-year national strategy with guidance to National Health Service providers on the phased uptake approach of HCL systems. The guidance applies nationally, including to Romford. Rollout started last year. Further information is available at the following link:
https://www.nice.org.uk/guidance/ta943
NHS England also commissions diabetes digital structured education services, which support users to self-manage their condition.
Asked by: Andrew Rosindell (Reform UK - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he has taken to help reduce cases of hyperglycaemia in a) England and b) the parliamentary constituency of Romford.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) has published advice on the management of type 1 diabetes, including advice on managing hypoglycaemia and hyperglycaemia, which is available at the following link:
https://cks.nice.org.uk/topics/diabetes-type-1/management/
NICE’s guidance includes the use of hybrid close loops (HCL) for type 1 diabetes which provide real time monitoring of glucose levels and administer insulin when needed to prevent hypoglycaemia and hyperglycaemia.
Following NICE’s guidance, NHS England developed a five-year national strategy with guidance to National Health Service providers on the phased uptake approach of HCL systems. The guidance applies nationally, including to Romford. Rollout started last year. Further information is available at the following link:
https://www.nice.org.uk/guidance/ta943
NHS England also commissions diabetes digital structured education services, which support users to self-manage their condition.
Asked by: Andrew Rosindell (Reform UK - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many instances of neglect by NHS visiting carers have been reported in (a) England and (b) Romford constituency in every year since 2010.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Providers of National Health Services are responsible for collating organisational safeguarding data. Local authorities will hold data on referrals made on adult safeguarding to them by NHS or independent health services.
At a national level, annual data on safeguarding adult referrals, including data on neglect and the location of risk, based on local authority area is published and available at the following link:
https://digital.nhs.uk/data-and-information/publications/statistical/safeguarding-adults
Asked by: Andrew Rosindell (Reform UK - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many instances of patient neglect by NHS employees have been reported in (a) England and (b) Romford constituency in every year since 2010.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Providers of National Health Services are responsible for collating organisational safeguarding data. Local authorities will hold data on referrals made on adult safeguarding to them by NHS or independent health services.
At a national level, annual data on safeguarding adult referrals, including data on neglect and the location of risk, based on local authority area is published and available at the following link:
https://digital.nhs.uk/data-and-information/publications/statistical/safeguarding-adults
Asked by: Andrew Rosindell (Reform UK - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment has been made of the proportion of terminated NICE health technology appraisals that are for blood cancer treatments compared to other cancers.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Since August 2019, 31% of National Institute for Health and Care Excellence (NICE) technology appraisals for blood cancer treatments were terminated as the company withdrew from the NICE appraisal process. For the same period, 21% of appraisals for all cancers were terminated.
Between 2019 and 2025 so far, 93% of blood cancer treatment recommendations in completed NICE appraisals were positive, which is higher than the rate across the whole NICE portfolio. NICE has also recommended more treatments for blood cancers in draft guidance that are now available to eligible patients through the Cancer Drugs Fund.
NICE strives to get the best care to patients fast and ensure value for the taxpayer. The aligned NICE and Medicines and Healthcare products Regulatory Agency pathway, set out in the 10-Year Health Plan, will allow NICE to bring medicines to patients three to six months sooner. NICE also continues to support and work with companies to identify the best time to submit appraisals and to ensure they have a clear understanding of NICE’s methods and processes, to try and avoid terminations.
Asked by: Andrew Rosindell (Reform UK - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps are being taken to improve patient access to clinically effective new blood cancer treatments for NHS patients.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. NHS England funds NICE-recommended cancer medicines from the Cancer Drugs Fund from the point of positive draft NICE guidance, bringing forward patient access by approximately five months than would otherwise be the case.
For the years 2023/24 to 2024/25, NICE recommended 25 medicines to treat blood cancer that are now available for the treatment of NHS patients.